tecartus
kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymphoma, mantle-cell - daganatellenes szerek - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).
letifend
leti pharma, s.l.u. - recombinant protein q from leishmania infantum mon-1 - inaktivált bakteriális oltóanyagok (beleértve a mycoplasma, toxoid, valamint chlamydia) - kutyák - 6 hónapos korú kutyák aktív immunizálására, hogy csökkentse a leishmaniasis klinikai esete kialakulásának kockázatát.
ovugel
vetoquinol - triptorelin acetate - hipofízis és hypothalamus hormonok és analógok - pigs (sows for reproduction) - for the synchronisation of ovulation in weaned sows to enable a single fixed-time artificial insemination.
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - daganatellenes szerek - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
asmanex twisthaler 400 mikrogramm por inhalációhoz
msd pharma hungary kft. - expozíció -
elocom 0,1% kenőcs
organon hungary kft. - expozíció -
elocom 0,1% krém
organon hungary kft. - expozíció -
elocom 0,1% oldat
organon hungary kft. - expozíció -
asmanex twisthaler 200 mikrogramm por inhalációhoz
msd pharma hungary kft. - expozíció -
momegen 1 mg/g kenőcs
viatris ltd. - expozíció -